Funding from Movember aiding marginalized communities.

2023-11-07 00:38:53 - Dr. Sam Nine Dr. Sam Nine is a renowned urologist with over 20 years of experience in the field. Recognizing the need for more resources dedicated to men's sexual health, he created With his commitment to providing accurate information and fostering open discussions, he has become a pioneering figure in promoting healthier, stigma-free attitudes towards men's health.


, ,
    1. , , , , , ,
      tags will remain the same. The English text content will be thoroughly and creatively rewritten by replacing every expression, wording, or grammatical construct with its synonym or equivalent. Foreign language, technical jargon, acronyms, or names will remain unchanged. The information will stay the same, and the English text will remain fluent and idiomatic. The HTML tags and their content will remain the same.

      "Movember, the yearly mustache-growing fundraiser, is commemorating 20 years of revolutionizing men’s health — 17 of those right here in Canada.

      Today, we’re exploring where some of those fundraising dollars go.

      In September, Movember disclosed an investment in prostate cancer research throughout Canada, amounting to a total of $5.8 million. That includes $2.1 million for the Health Equity Grants Initiative.

      “So, it’s truly focused on groups that are traditionally underrepresented and have disproportionately unfavorable outcomes for prostate cancer or otherwise what tend to be feeble experiences with the healthcare system or prostate cancer, specifically,” stated Dr. Mike Fraser, Movember’s director of Cancer Program Implementation.

      “These are Black men, men of African-Caribbean descent who have a twofold higher risk of developing prostate cancer, and that cancer tends to be more aggressive. It is Indigenous men who, again, have a much worse outcome for prostate cancer than non-Indigenous men,” he added.

      “This grant really is focused on determining the causes of these groups' disproportionately poorer outcomes, as well as implementing programs that are designed to alleviate those inequities.”

      The $5.8 million will also finance the Preventing Disease Progression in Prostate Cancer Program, the Personalized Active Surveillance Program, and the Patient-Reported Outcome Measures (PROMS) Program.

      Showing page 1 of 8